
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🔥 15 hours ago
🏄 California, Colorado, +3 more states – Remote
💵 $220k - $250k / year
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 9%
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Provide strategic leadership for Kyverna’s Field Medical function across Western USA, setting the vision, priorities, and operating framework for regional scientific engagement and external collaboration • Develop, lead, and maintain high-impact, long-term relationships with healthcare professionals, key opinion leaders, clinical investigators, academic research centers, professional societies, and patient advocacy groups • Serve as a senior scientific ambassador for Kyverna’s cell therapy platform and autoimmune disease portfolio • Shape Medical Affairs strategy by synthesizing field insights, protocol feedback, treatment landscape evolution, unmet needs, real-world practice patterns, and competitive intelligence • Provide senior oversight and partnership with clinical trial sites to anticipate and resolve barriers to identification, screening, enrollment, and retention • Support commercial site activation, operational readiness, and optimal study execution as a member of the site activation team • Oversee regional scientific activities including advisory boards, congress planning, symposium support, investigator meetings, and scientific engagement initiatives • Represent Kyverna at major international conferences as a senior leader • Support evaluation and development of investigator-initiated trials, scientific collaborations, and research partnerships • Build and mentor a high-performing regional MSL organization, including talent acquisition, training, coaching, and performance management • Ensure strategic alignment and cross-functional collaboration with Clinical Development, Safety, Regulatory, Commercial, Market Access, and Corporate Affairs • Maintain current expertise in autoimmune disease, cellular therapy, neuromuscular disorders, and emerging scientific literature • Champion compliance, ethical scientific exchange, and adherence to applicable laws, regulations, and company policies • Travel extensively across the region, up to 50 percent, including occasional weekends and short-notice requests
• 10+ years of progressive Medical Affairs experience with at least 5 years in a senior management or field leadership role, within neuromuscular therapeutics • Advanced scientific or medical degree (PhD, PharmD, MD, or equivalent) required • Demonstrated success developing and executing regional or global Medical Affairs strategies, including scientific engagement, evidence generation, and cross-functional alignment • Strong expertise in Myasthenia Gravis or related neuromuscular disorders strongly preferred • Expertise in neuroimmunology disorders also highly desirable • Proven ability to build, lead, mentor, and inspire high-performing MSL or field-medical teams • Exceptional verbal, written, and interpersonal communication skills with the ability to convey complex science and influence senior stakeholders • Highly strategic thinker with strong operational discipline; demonstrates independent judgment, adaptability, and the ability to manage multiple priorities in a dynamic environment • Strong collaborative mindset with a track record of successfully partnering across Clinical Development, Regulatory, Commercial, and Executive Leadership teams • Ability to travel extensively across the region, up to 50 percent, including occasional weekends and short-notice requests
• Bonus eligibility • Benefits • Participation in Company’s stock plan • Remote work arrangement
Apply Now🔥 16 hours ago
Clinical Director leading post-discharge care operations for a healthcare services and technology company. Improving transitions, clinical workflows, readmissions, and health-plan quality measures.
🔥 17 hours ago
Medical Director reviewing complex healthcare appeals and guiding utilization management for Centene. Improving care quality, cost-effectiveness, and provider performance.
🔥 19 hours ago
Remote Medicare Medical Director guiding utilization, quality, and care management for Centene healthcare members. Reviewing complex cases and leading medical quality initiatives across eight U.S. states.
🕒 3 days ago
Medical Affairs Director leading clinical strategy, scientific engagement, and evidence generation for Encoded Therapeutics’ gene therapy programs. Supporting chronic pain and early-stage clinical development.
🕒 3 days ago
Clinical science director advancing nephrology clinical programs at rare-disease biopharmaceutical Travere Therapeutics. Leading trials, regulatory submissions, data interpretation, and scientific communications.